Acumen Pharmaceuticals, Inc. Earnings Per Share (Basic)
Acumen Pharmaceuticals, Inc. (ABOS) reported Earnings Per Share (Basic) of -$0.45 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Acumen Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.45.
- Acumen Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.33.
- Acumen Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.41.
- Acumen Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.44.
- Acumen Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was -$2.00.
- Acumen Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was -$1.71.
- Acumen Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was -$1.08.
- Acumen Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was -$1.06.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.45 10-Q · filed 2026-08-12 | -$0.79 10-Q · filed 2026-08-12 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.64 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2026-03-31 | -$0.33 10-Q · filed 2026-05-12 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.85 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.53 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.00 10-K · filed 2026-03-26 |
| 2025-09-30 | -$0.44 10-Q · filed 2025-11-12 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.59 10-Q · filed 2025-11-12 | -$2.21 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-06-30 | -$0.68 10-Q · filed 2026-08-12 | -$1.15 10-Q · filed 2026-08-12 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.27 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-03-31 | -$0.48 10-Q · filed 2026-05-12 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.59 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-05-12 |
| 2024-12-31 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.46 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.71 10-K · filed 2026-03-26 |
| 2024-09-30 | -$0.50 10-Q · filed 2025-11-12 | -$0.84 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.09 10-Q · filed 2025-11-12 | -$1.37 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.34 10-Q · filed 2025-08-12 | -$0.59 10-Q · filed 2025-08-12 | -$0.88 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$1.12 derived: net income ÷ weighted average shares · filed 2025-08-12 |
| 2024-03-31 | -$0.25 10-Q · filed 2025-05-13 | -$0.53 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$0.77 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.05 derived: net income ÷ weighted average shares · filed 2025-05-13 |
| 2023-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.80 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.08 10-K · filed 2025-03-27 |
| 2023-09-30 | -$0.24 10-Q · filed 2024-11-12 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.79 10-Q · filed 2024-11-12 | -$1.10 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.28 10-Q · filed 2024-08-13 | -$0.56 10-Q · filed 2024-08-13 | -$0.87 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$1.14 derived: net income ÷ weighted average shares · filed 2024-08-13 |
| 2023-03-31 | -$0.28 10-Q · filed 2024-05-14 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.85 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.11 derived: net income ÷ weighted average shares · filed 2024-05-14 |
| 2022-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$0.58 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$0.83 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$1.06 10-K · filed 2024-03-26 |
| 2022-09-30 | -$0.26 10-Q · filed 2023-11-13 | -$0.52 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.74 10-Q · filed 2023-11-13 | -$0.95 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-06-30 | -$0.25 10-Q · filed 2023-08-08 | -$0.48 10-Q · filed 2023-08-08 | -$0.68 derived: net income ÷ weighted average shares · filed 2023-08-08 | -$0.79 derived: net income ÷ weighted average shares · filed 2023-08-08 |
| 2022-03-31 | -$0.23 10-Q · filed 2023-05-09 | -$0.43 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$2.76 derived: net income ÷ weighted average shares · filed 2023-05-09 |
| 2021-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$2.78 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$5.02 10-K · filed 2023-03-27 |
| 2021-09-30 | -$0.10 10-Q · filed 2022-11-14 | -$3.37 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$7.00 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$141.93 10-Q · filed 2022-08-15 | -$207.52 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |